Details for 2018756531
Up to date per 09.04.2026
Actions
Details for 2018756531
Granted/Registered
European Patent
17.06.2020 A
12.07.2023 B1
10.08.2017
US
201762543658 P
08.11.2017
US
201762583314 P
15.02.2018
WO
PCT/US2018/018371
C07K 14/79 20060101AFI20230123BHEP
Owner
Denali Therapeutics Inc.161 Oyster Point Boulevard South San Francisco, California 94080US
Representative
No representatives present
Inventor
CHEN, Xiaochengc/o Denali Therapeutics Inc. 151 Oyster Point Blvd. 2nd Floor South San Francisco California 94080US
DENNIS, Mark S.c/o Denali Therapeutics Inc. 151 Oyster Point Blvd. 2nd Floor South San Francisco California 94080US
KARIOLIS, Mihalisc/o Denali Therapeutics Inc. 151 Oyster Point Blvd. 2nd Floor South San Francisco California 94080US
SILVERMAN, Adam P.c/o Denali Therapeutics Inc. 151 Oyster Point Blvd. 2nd Floor South San Francisco California 94080US
SRIVASTAVA, Ankitac/o Denali Therapeutics Inc. 151 Oyster Point Blvd. 2nd Floor South San Francisco California 94080US
WATTS, Ryan J.c/o Denali Therapeutics Inc. 151 Oyster Point Blvd. 2nd Floor South San Francisco California 94080US
WELLS, Robert C.c/o Denali Therapeutics Inc. 151 Oyster Point Blvd. 2nd Floor South San Francisco California 94080US
ZUCHERO, Joy Yuc/o Denali Therapeutics Inc. 151 OysterPoint Blvd. 2nd Floor South San Francisco California 94080US
Information about Fees